Stocks · Healthcare · Medical - Devices
LENSAR Inc LNSR
$6.67 -1.19% Close, Oct 5, 2026 · NASDAQ · Market cap $82.9M
Weak trendInexpensive vs sector
Next earnings report: Nov 12, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- The diluted share count rose 92.9% in a year.
- Operating margin widened to -13.5% from -24.6% a year earlier.
- Over the past year the stock returned -46.3%, behind the S&P 500 by 62.1 percentage points.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 6, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Bottom 36%
- Revenue growth, 3-year CAGRTop 33%
- Revenue growth accelerationTop 27%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 47%
- Gross marginBottom 32%
- Operating marginBottom 45%
- Cash conversion (OCF / net income)Bottom 5%
- Accruals (lower is better)Bottom 1%
- Net debt / EBITDA (lower is better)Top 28%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 43%
- Free-cash-flow yieldBottom 39%
- EBITDA / enterprise valueTop 1%
- Sales / enterprise valueTop 13%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 15%
- 6-month returnTop 45%
- 1-year return vs S&P 500Bottom 12%
- Distance from 52-week highBottom 31%
- Trend checklist (0–4)Bottom 13%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 4%
- Consecutive EPS beatsTop 35%
- Share of analysts rating BuyBottom 34%
- Upside to consensus price targetTop 43%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Bottom 25%
- Maximum drawdown, 3 yearsTop 50%
- Beta vs S&P 500 (lower is better)Top 42%
- Net debt / EBITDA (lower is better)Top 28%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 1.1% | 3.3% | ↑ |
| Gross margin | 47.2% | 48.0% | ↑ |
| Operating margin | -24.6% | -13.5% | ↑ |
| FCF margin | -9.0% | -12.2% | ↓ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 3.3% | 1.1% | ↑ | Bottom 36% |
| Gross margin | 48.0% | 47.2% | ↑ | Bottom 32% |
| Operating margin | -13.5% | -24.6% | ↑ | Bottom 45% |
| Net margin | 57.6% | -84.5% | ↑ | — |
| Free-cash-flow margin | -12.2% | -9.0% | ↓ | — |
| Return on invested capital | -16.0% | — | Top 47% | |
| Revenue growth, 3-year CAGR | 18.2% | — | Top 33% |
Quality of earnings and balance sheet
- Cash conversion (OCF / net income)Above 1× means profits are backed by cash.
- -0.21×
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- 60.4%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 3.4%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- +21.2 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- -0.31×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- -0.60%
- Shareholder yield
- -0.60%
- Share count change, 1 year
- +92.9%
- Share count change, 3-year CAGR
- +28.6%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 13, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 2
- Beats in the last 8 reports
- 3 of 8
- Average EPS surprise, last 4
- +100.0%
- Average 2-day reaction, last 8
- +7.8%
- Positive 20 days after report
- 4 of 8
Analysts
- Consensus price target
- $12.00
- Target vs current price
- +79.9%
- Analysts with a rating
- 3
- Share rating Buy or Strong Buy
- 67%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 13, 2026 | +160.6% | +31.5% | +38.6% | +28.0% | — |
| May 8, 2026 | +743.2% | +7.8% | +11.5% | +7.1% | +6.7% |
| Mar 31, 2026 | -80.7% | +1.5% | -4.1% | -8.9% | +4.6% |
| Nov 6, 2025 | -210.0% | -8.6% | -16.9% | -9.0% | -0.8% |
| Aug 7, 2025 | -87.5% | -1.5% | -2.1% | -6.6% | -7.5% |
| May 8, 2025 | -1446.7% | -0.1% | +2.5% | -5.6% | -6.4% |
| Feb 27, 2025 | -794.4% | +14.8% | +62.0% | +49.3% | +47.6% |
| Nov 7, 2024 | +55.2% | +17.2% | +26.1% | +23.9% | +97.8% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 13, 2026 | $0.10 | -$0.17 | +160.6% | $16.5M |
| May 8, 2026 | $1.56 | $0.19 | +743.2% | $12.6M |
| Mar 31, 2026 | -$0.12 | -$0.07 | -80.7% | $12.7M |
| Nov 6, 2025 | -$0.31 | -$0.10 | -210.0% | $14.3M |
| Aug 7, 2025 | -$0.15 | -$0.08 | -87.5% | $13.9M |
| May 8, 2025 | -$2.32 | -$0.15 | -1446.7% | $14.2M |
| Feb 27, 2025 | -$1.61 | -$0.18 | -794.4% | $16.7M |
| Nov 7, 2024 | -$0.13 | -$0.29 | +55.2% | $13.5M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (forward) | 855.1× | — | — | — |
| EV / EBITDA | 2.0× | — | — | Top 1% |
| EV / Sales | 1.19× | — | — | Top 13% |
| Free-cash-flow yield | -8.84% | — | — | Bottom 39% |
| Earnings yield | -4.95% | — | — | Top 43% |
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✗ Price above 200-day average
- ✗ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 0
- 50-day average slope (20 days)
- +8.5%
- 200-day average slope (20 days)
- -4.1%
- Distance from 50-day average
- -8.0%
- Distance from 200-day average
- -16.5%
- RSI (14)
- 36.9
- Relative volume
- 0.82×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 73.4%
- Volatility vs own 5-year history
- 67th percentile · Normal for this stock
- Beta vs S&P 500 (2 years, weekly)
- 0.97
- Correlation with S&P 500
- 0.21
- Current drawdown from 1-year high
- -47.6%
- Maximum drawdown, 3 years
- -70.3%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Oct 5, 2020 | Nov 8, 2023 | -83.5% | 779 days | 326 days (Feb 28, 2025) |
| Mar 19, 2025 | Jul 31, 2026 | -70.3% | 343 days | Not yet recovered |
| Mar 5, 2025 | Mar 10, 2025 | -15.4% | 3 days | 2 days (Mar 12, 2025) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $82.9M
- EPS, diluted (TTM)
- -$0.33
- Revenue (TTM)
- $60.3M
- 52-week range
- $4.95 – $12.94
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $34.5M | $35.4M | $42.2M | $53.5M | $58.4M |
| Gross profit | $17.8M | $20.0M | $21.1M | $25.9M | $27.1M |
| Operating income | -$19.7M | -$20.2M | -$12.2M | -$10.7M | -$24.6M |
| Net income | -$19.6M | -$19.9M | -$14.4M | -$31.4M | -$34.3M |
| EPS (diluted) | -$2.10 | -$1.96 | -$1.31 | -$2.73 | -$2.87 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $13.5M | $16.7M | $14.2M | $13.9M | $14.3M | $16.0M | $13.4M | $16.5M |
| Net income | -$1.5M | -$18.7M | -$27.3M | -$1.8M | -$3.7M | -$1.5M | $36.3M | $3.5M |
| EPS (diluted) | -$0.13 | -$1.61 | -$2.32 | -$0.15 | -$0.31 | -$0.12 | $0.00 | $0.10 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | -$9.0M | -$14.9M | -$9.7M | -$2.3M | -$14.8M |
| Capital expenditure | -$354,000 | -$115,000 | -$236,000 | -$156,000 | -$83,000 |
| Free cash flow | -$9.3M | -$15.0M | -$9.9M | -$2.4M | -$14.9M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $361,000 | $408,000 | $5.9M | $58,000 | $258,000 |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $13.6M
- Total assets
- $69.6M
- Total liabilities
- $54.7M
- Total debt
- $2.4M
- Net debt
- -$11.2M
- Shareholders’ equity
- $14.9M
As of Jun 30, 2026 (filed Aug 13, 2026).
Short interest
- Shares sold short
- 338,227
- Days to cover
- 4.27
- Change vs previous report
- -11.4%
FINRA short interest, settlement date Sep 15, 2026.